Company intelligence
nuaxia
The Professional Network for Healthcare Experts
About nuaxia
nuaxia is an AI-powered healthcare information technology platform that empowers doctors, healthcare professionals and patients to learn, earn and network. nuaxia specialises in medical education assessment, educational needs and patient impact studies. Our global network of 6.1 million verified HCP's, our proven expertise in our specialist field, our commitment to leading-edge data science and AI solutions and our ability to leverage 40k prior engagements empowers us to provide market research assurance for a medical affairs budget. nuaxia, your unique partner for independently validated educational studies.
Verified activity
Signals from nuaxia
2 published signals
Strategy & Corporate Development
nuaxia announced that Sudarshan Pharma is making a move into advanced oncology by approving the acquisition of a 9.5% stake in US-based MedTherapy Biotechnology.
Reported by nuaxia
Strategy & Corporate Development
nuaxia reports that Roche has signed an exclusive global licensing agreement for Simcere Zaiming's SIM0660 trispecific antibody targeting CD79a, CD19, and CD3, with Simcere receiving $75 million upfront and up to $1.53 billion in total payments.
Reported by nuaxia